Arcus Biosciences Statistics
Total Valuation
RCUS has a market cap or net worth of $1.30 billion. The enterprise value is $303.81 million.
| Market Cap | 1.30B |
| Enterprise Value | 303.81M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
RCUS has 90.95 million shares outstanding. The number of shares has increased by 18.08% in one year.
| Shares Outstanding | 90.95M |
| Shares Change (YoY) | +18.08% |
| Shares Change (QoQ) | +14.63% |
| Owned by Insiders (%) | 40.86% |
| Owned by Institutions (%) | 59.86% |
| Float | 50.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.48 |
| Forward PS | 10.20 |
| PB Ratio | 1.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.22, with zero debt.
| Current Ratio | 5.22 |
| Quick Ratio | 5.05 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -41.00% and return on invested capital (ROIC) is -38.19%.
| Return on Equity (ROE) | -41.00% |
| Return on Assets (ROA) | -19.30% |
| Return on Capital (ROIC) | -38.19% |
| Revenue Per Employee | $410,745 |
| Profits Per Employee | -$400,347 |
| Employee Count | 577 |
| Asset Turnover | 0.20 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, RCUS has paid $4.00 million in taxes.
| Income Tax | 4.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.77% in the last 52 weeks. The beta is 0.89, so RCUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -27.77% |
| 50-Day Moving Average | 15.76 |
| 200-Day Moving Average | 16.34 |
| Relative Strength Index (RSI) | 40.97 |
| Average Volume (20 Days) | 804,975 |
Short Selling Information
The latest short interest is 6.16 million, so 6.77% of the outstanding shares have been sold short.
| Short Interest | 6.16M |
| Short Previous Month | 7.43M |
| Short % of Shares Out | 6.77% |
| Short % of Float | 12.09% |
| Short Ratio (days to cover) | 6.46 |
Income Statement
In the last 12 months, RCUS had revenue of $237.00 million and -$231.00 million in losses. Loss per share was -$3.11.
| Revenue | 237.00M |
| Gross Profit | 237.00M |
| Operating Income | -270.00M |
| Pretax Income | -227.00M |
| Net Income | -231.00M |
| EBITDA | -210.00M |
| EBIT | -227.00M |
| Loss Per Share | -$3.11 |
Balance Sheet
The company has $995.00 million in cash and no debt, giving a net cash position of $995.00 million or $10.94 per share.
| Cash & Cash Equivalents | 995.00M |
| Total Debt | n/a |
| Net Cash | 995.00M |
| Net Cash Per Share | $10.94 |
| Equity (Book Value) | 707.00M |
| Book Value Per Share | 7.77 |
| Working Capital | 860.00M |
Cash Flow
In the last 12 months, operating cash flow was -$210.00 million and capital expenditures -$25.00 million, giving a free cash flow of -$235.00 million.
| Operating Cash Flow | -210.00M |
| Capital Expenditures | -25.00M |
| Free Cash Flow | -235.00M |
| FCF Per Share | -$2.73 |
Margins
Gross margin is 100.00%, with operating and profit margins of -113.92% and -97.47%.
| Gross Margin | 100.00% |
| Operating Margin | -113.92% |
| Pretax Margin | -95.78% |
| Profit Margin | -97.47% |
| EBITDA Margin | -88.61% |
| EBIT Margin | -95.78% |
| FCF Margin | -99.16% |
Dividends & Yields
RCUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.08% |
| Shareholder Yield | -18.08% |
| Earnings Yield | -17.79% |
| FCF Yield | -18.09% |
Analyst Forecast
The average price target for RCUS is $39.30, which is 175.21% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.30 |
| Price Target Difference | 175.21% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 34.17% |
| EPS Growth Forecast (5Y) | -6.94% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
RCUS has an Altman Z-Score of 0.81 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.81 |
| Piotroski F-Score | 2 |